OSM-LIF Receptors
Cell surface receptors formed from the dimerization of LIF RECEPTOR ALPHA SUBUNIT with CYTOKINE RECEPTOR GP130. Although originally described as receptors for LEUKEMIA INHIBITORY FACTOR these receptors also bind the closely-related protein ONCOSTATIN M and are referred to as both LIF receptors and type I oncostatin M receptors.
Also Known As:
Receptors, OSM-LIF; LIF Receptors; Leukemia Inhibitory Factor Receptors; Leukemia Inhibitory Factor-Oncostatin M Shared Receptor; Oncostatin M Type I Receptor; Oncostatin M-Leukemia Inhibitory Factor Shared Receptor; Leukemia Inhibitory Factor Oncostatin M Shared Receptor; Oncostatin M Leukemia Inhibitory Factor Shared Receptor; Receptors, LIF; Receptors, OSM LIF; Leukemia Inhibitory Factor Receptor; Receptors, Leukemia Inhibitory Factor
Networked: 84
relevant articles (0 outcomes,
7 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Ding, Yufeng:
2 articles
(01/2022 - 01/2019)
|
2. | Shao, Jialiang:
2 articles
(01/2022 - 01/2019)
|
3. | Wang, Xiang:
2 articles
(01/2022 - 01/2019)
|
4. | Wang, Xiongjun:
2 articles
(01/2022 - 01/2019)
|
5. | Yu, Hua:
2 articles
(01/2022 - 01/2019)
|
6. | Clements, Miranda E:
2 articles
(12/2021 - 01/2021)
|
7. | Johnson, Rachelle W:
2 articles
(12/2021 - 01/2021)
|
8. | Altwegg, Kristin A:
2 articles
(08/2021 - 08/2019)
|
9. | Li, Xiaonan:
2 articles
(08/2021 - 08/2019)
|
10. | Nair, Hareesh B:
2 articles
(08/2021 - 08/2019)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures